← Best peptides for Weight Loss & Metabolic HealthSee the PubMed search behind the study count ↗
Weight Loss & Metabolic Health · #3 most researched
Retatrutide
Also known as: LY3437943
Investigational triple agonist; added glucagon-receptor activity contributes an energy-expenditure effect on top of appetite suppression. Not yet FDA-approved.
Research use only. Nothing here is medical advice; this compound is not approved for human consumption outside prescription use.
Retatrutide at a glance
MechanismGLP-1/GIP/glucagon triple agonist
Evidence tierHuman trials
Regulatory statusInvestigational (Phase III)
Indexed studies160
Approx. half-lifeAbout 6 days
Studied routeSubcutaneous injection
Vial sizes on file10 mg
Tracked vendors1 (1 verified)
Where to buy Retatrutide
Verified vendors first, then lowest price
Research areas
Triple-agonist signallingEnergy expenditureLiver fat
Commonly researched alongside
VialCheck record
We track 1 vendor listing Retatrutide. 1 of them (100%) have verified batches on file with VialCheck. Lowest price is not the same as lowest risk — check the batch COA before you order.